Serviços Personalizados
Journal
Artigo
Espanhol (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Similares em
SciELO
Compartilhar
Permalink
Gaceta mexicana de oncología
versão On-line ISSN 2565-005Xversão impressa ISSN 1665-9201
Resumo
CERVANTES-ZAMORA, Antonio et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) + Cytoreductive surgery in ovarian cancer. Gac. mex. oncol. [online]. 2022, vol.21, suppl.1, pp.102-104. Epub 11-Set-2023. ISSN 2565-005X. https://doi.org/10.24875/j.gamo.22000005.
Background:
Ovarian cancer is the fifth leading cause of cancer death and the prevalence with peritoneal metastasis is high, with a low possibility of cure.
Case presentation:
33-year-old patient with ovarian cancer and peritoneal metastasis treated with Radical Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy and disease-free at 2 years of follow-up.
Discussion:
There is evidence of increased survival of intraperitoneal chemotherapy, with a 21% reduction in the risk of death.
Conclusion:
This treatment can be applied as a promising and possibly curative option for this disease.
Palavras-chave : Carcinomatosis; Cancer; Ovary; HIPEC.
